BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33325558)

  • 1. Immunosuppression considerations in simultaneous organ transplant.
    Kovac D; Choe J; Liu E; Scheffert J; Hedvat J; Anamisis A; Salerno D; Lange N; Jennings DL
    Pharmacotherapy; 2021 Jan; 41(1):59-76. PubMed ID: 33325558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic aspects of multiple organ transplantation.
    Zivković SA
    Handb Clin Neurol; 2014; 121():1305-17. PubMed ID: 24365421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Organ Transplantation: Heart, Lung, Kidney, Liver, and Simultaneous Liver-Kidney.
    Scheuher C
    Crit Care Nurs Q; 2016; 39(3):199-206. PubMed ID: 27254636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of immunosuppressive usage in pancreas transplantation.
    Stratta RJ
    Clin Transplant; 1999 Feb; 13(1 Pt 1):1-12. PubMed ID: 10081628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.
    Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
    Clin Transplant; 2015 Nov; 29(11):978-90. PubMed ID: 26278925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of organ transplantation.
    Patchell RA
    Ann Neurol; 1994 Nov; 36(5):688-703. PubMed ID: 7979215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined organ effect: protection against rejection?
    Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
    Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CKD in Recipients of Nonkidney Solid Organ Transplants: A Review.
    Wiseman AC
    Am J Kidney Dis; 2022 Jul; 80(1):108-118. PubMed ID: 34979161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression.
    Selby R; Ramirez CB; Singh R; Kleopoulos I; Kusne S; Starzl TE; Fung J
    Arch Surg; 1997 Mar; 132(3):304-10. PubMed ID: 9125033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in pancreas transplantation: progress, problems and perspective.
    Stratta RJ
    Transpl Immunol; 1998 Jun; 6(2):69-77. PubMed ID: 9777694
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac operations in solid-organ transplant recipients.
    Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
    Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreas transplant protocols at the University of Minnesota: recipient and donor selection, operative and postoperative management, and outcome.
    Sutherland DE; Moudry KC; Elick BA; Goetz FC; Najarian JS
    Clin Transpl; 1987; ():109-26. PubMed ID: 3154373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and long-term outcomes for solid organ transplant. Quality of life in solid organ transplant recipients].
    Daga Ruiz D; Fernández Aguirre C; Segura González F; Carballo Ruiz M
    Med Intensiva; 2008; 32(6):296-303. PubMed ID: 18601837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients.
    Al Sagheer T; Enderby CY
    Clin Transplant; 2019 Oct; 33(10):e13727. PubMed ID: 31587353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.